首页 > 最新文献

Sleep Medicine Reviews最新文献

英文 中文
How does the brain “know” when it has had enough sleep? A hypothesis 大脑是如何“知道”自己已经睡够了呢?一个假设
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-02-01 Epub Date: 2026-01-28 DOI: 10.1016/j.smrv.2026.102230
Thomas J. Balkin, Allen R. Braun
According to the two process model, sleep timing and duration are determined by the interaction of process S (the sleep homeostat) and process C (the circadian drive for alertness). Although originally invoked to account only for sleep inertia effects (post-awakening performance deficits), there is evidence that process W is also active during sleep, and that it serves a sleep-preserving function that is partly independent of processes S and C. This suggests that initiation of the natural, spontaneous awakening process at the end of an adequately restorative sleep period is not passively triggered by the combined effects of a reduced process S and an ascendant process C alone – it also requires that a process W-mediated barrier against awakening be breached. It is hypothesized that one function of REM sleep is to periodically test the level of stimulation needed to breach this barrier, with the extent to which cortical reactivation occurs during REM sleep reflecting the brain's level of sleep satiation. It is further hypothesized that this REM-elicited neuronal reactivation information is processed (possibly in the medial prefrontal cortex) to determine readiness for awakening, and this information is communicated (e.g., via the lateral hypothalamus) to the REM/NREM and sleep/wake “flip-flop” switches that either initiate awakening or the return to NREM sleep, as appropriate.
根据双过程模型,睡眠时间和持续时间由过程S(睡眠稳态器)和过程C(警觉性的昼夜驱动)的相互作用决定。虽然最初只是为了解释睡眠惯性效应(觉醒后的表现缺陷),但有证据表明,W过程在睡眠期间也很活跃,并且它具有部分独立于S和c过程的睡眠保持功能。在充分恢复睡眠期结束时的自发觉醒过程不是由过程S的减少和过程C的上升单独的联合作用被动触发的,它还需要过程w介导的觉醒障碍被打破。据推测,快速眼动睡眠的一个功能是定期测试打破这一屏障所需的刺激水平,快速眼动睡眠期间皮层再激活的程度反映了大脑的睡眠满足程度。进一步的假设是,快速眼动引起的神经元再激活信息被处理(可能在内侧前额叶皮层),以确定觉醒的准备情况,并将这些信息(例如,通过外侧下丘脑)传达给快速眼动/非快速眼动和睡眠/觉醒的“触发器”开关,这些开关或启动觉醒,或适当地返回到非快速眼动睡眠。
{"title":"How does the brain “know” when it has had enough sleep? A hypothesis","authors":"Thomas J. Balkin,&nbsp;Allen R. Braun","doi":"10.1016/j.smrv.2026.102230","DOIUrl":"10.1016/j.smrv.2026.102230","url":null,"abstract":"<div><div>According to the two process model, sleep timing and duration are determined by the interaction of process S (the sleep homeostat) and process C (the circadian drive for alertness). Although originally invoked to account only for sleep inertia effects (post-awakening performance deficits), there is evidence that process W is also active during sleep, and that it serves a sleep-preserving function that is partly independent of processes S and C. This suggests that initiation of the natural, spontaneous awakening process at the end of an adequately restorative sleep period is not passively triggered by the combined effects of a reduced process S and an ascendant process C alone – it also requires that a process W-mediated barrier against awakening be breached. It is hypothesized that one function of REM sleep is to periodically test the level of stimulation needed to breach this barrier, with the extent to which cortical reactivation occurs during REM sleep reflecting the brain's level of sleep satiation. It is further hypothesized that this REM-elicited neuronal reactivation information is processed (possibly in the medial prefrontal cortex) to determine readiness for awakening, and this information is communicated (e.g., via the lateral hypothalamus) to the REM/NREM and sleep/wake “flip-flop” switches that either initiate awakening or the return to NREM sleep, as appropriate.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102230"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sponsorship bias and control group composition in trials evaluating digital cognitive behavioral therapy for insomnia – A comment on Grolig et al. 在评估数字认知行为治疗失眠的试验中赞助者偏见和对照组组成——对Grolig等人的评论。
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2026-02-01 Epub Date: 2026-01-23 DOI: 10.1016/j.smrv.2026.102243
Gabriel Natan Pires , Viviane Akemi Kakazu , Ingrid Porto Araújo Leite , Sergio Tufik
{"title":"Sponsorship bias and control group composition in trials evaluating digital cognitive behavioral therapy for insomnia – A comment on Grolig et al.","authors":"Gabriel Natan Pires ,&nbsp;Viviane Akemi Kakazu ,&nbsp;Ingrid Porto Araújo Leite ,&nbsp;Sergio Tufik","doi":"10.1016/j.smrv.2026.102243","DOIUrl":"10.1016/j.smrv.2026.102243","url":null,"abstract":"","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"85 ","pages":"Article 102243"},"PeriodicalIF":9.7,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toward deeper understanding of maternal sleep during pregnancy and childhood health 更深入地了解母亲在怀孕期间的睡眠和儿童健康。
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-09-29 DOI: 10.1016/j.smrv.2025.102183
Ye Zhang , Zidi Ning , Jiajun Yuan , Shenghui Li
{"title":"Toward deeper understanding of maternal sleep during pregnancy and childhood health","authors":"Ye Zhang ,&nbsp;Zidi Ning ,&nbsp;Jiajun Yuan ,&nbsp;Shenghui Li","doi":"10.1016/j.smrv.2025.102183","DOIUrl":"10.1016/j.smrv.2025.102183","url":null,"abstract":"","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102183"},"PeriodicalIF":9.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145253581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing timing and dose of exogenous melatonin administration in neuropsychiatric pediatric populations: a meta-analysis on sleep outcomes 优化时间和剂量外源性褪黑素给药在神经精神儿科人群:睡眠结果的荟萃分析
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-08-30 DOI: 10.1016/j.smrv.2025.102158
Simone Bruno , Giovanni Cenerini , Letizia Lo Giudice , Francy Cruz-Sanabria , Davide Benedetti , Alessio Crippa , Simona Fiori , Raffaele Ferri , Gabriele Masi , Ugo Faraguna
Melatonin is known to be effective in improving sleep in pediatric patients affected by neurological and psychiatric conditions. However, no guidelines exist advising the most effective treatment schedule. This systematic review and meta-analysis aimed to identify the dose, time of administration and treatment duration associated with the maximal treatment efficacy. The systematic search, conducted across multiple databases following PRISMA guidelines and including studies published up to April 30, 2024, yielded 21 studies. Mean differences in sleep-related variables between the treatment and the placebo group were considered as study outcomes. Dose-response curves and meta-regression models were fitted to test the effect of treatment-related parameters. Melatonin significantly reduced Sleep onset latency and increased Sleep efficiency and Total sleep time. Sleep onset latency reduction was associated with an advancement in the time between administration with respect to bedtime, while increased Sleep efficiency and Total sleep time with longer treatment durations. Melatonin reached the maximal efficacy between 2 and 4 mg/day. Our results suggest a dose and time of administration that may enhance melatonin's sleep promoting effects (2–4 mg, 3 h before bedtime) and, if replicated by large clinical trials, could guide clinical practice in managing sleep disturbances in children experiencing neuropsychiatric conditions.
众所周知,褪黑素可以有效改善受神经和精神疾病影响的儿科患者的睡眠。然而,没有指导方针建议最有效的治疗方案。本系统综述和荟萃分析旨在确定与最大治疗效果相关的剂量、给药时间和治疗持续时间。根据PRISMA指南,在多个数据库中进行了系统搜索,包括截至2024年4月30日发表的研究,共获得21项研究。治疗组和安慰剂组之间睡眠相关变量的平均差异被视为研究结果。拟合剂量-反应曲线和元回归模型,检验治疗相关参数的影响。褪黑素显著降低睡眠潜伏期,提高睡眠效率和总睡眠时间。睡眠发作潜伏期的减少与两次给药之间就寝时间的提前有关,而睡眠效率和总睡眠时间的增加与治疗持续时间的延长有关。褪黑素在2至4毫克/天之间达到最大功效。我们的研究结果表明,服用褪黑素的剂量和时间可以增强褪黑素的睡眠促进作用(2-4毫克,睡前3小时),如果在大型临床试验中得到证实,可以指导临床实践,治疗患有神经精神疾病的儿童的睡眠障碍。
{"title":"Optimizing timing and dose of exogenous melatonin administration in neuropsychiatric pediatric populations: a meta-analysis on sleep outcomes","authors":"Simone Bruno ,&nbsp;Giovanni Cenerini ,&nbsp;Letizia Lo Giudice ,&nbsp;Francy Cruz-Sanabria ,&nbsp;Davide Benedetti ,&nbsp;Alessio Crippa ,&nbsp;Simona Fiori ,&nbsp;Raffaele Ferri ,&nbsp;Gabriele Masi ,&nbsp;Ugo Faraguna","doi":"10.1016/j.smrv.2025.102158","DOIUrl":"10.1016/j.smrv.2025.102158","url":null,"abstract":"<div><div>Melatonin is known to be effective in improving sleep in pediatric patients affected by neurological and psychiatric conditions. However, no guidelines exist advising the most effective treatment schedule. This systematic review and meta-analysis aimed to identify the dose, time of administration and treatment duration associated with the maximal treatment efficacy. The systematic search, conducted across multiple databases following PRISMA guidelines and including studies published up to April 30, 2024, yielded 21 studies. Mean differences in sleep-related variables between the treatment and the placebo group were considered as study outcomes. Dose-response curves and meta-regression models were fitted to test the effect of treatment-related parameters. Melatonin significantly reduced Sleep onset latency and increased Sleep efficiency and Total sleep time. Sleep onset latency reduction was associated with an advancement in the time between administration with respect to bedtime, while increased Sleep efficiency and Total sleep time with longer treatment durations. Melatonin reached the maximal efficacy between 2 and 4 mg/day. Our results suggest a dose and time of administration that may enhance melatonin's sleep promoting effects (2–4 mg, 3 h before bedtime) and, if replicated by large clinical trials, could guide clinical practice in managing sleep disturbances in children experiencing neuropsychiatric conditions.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102158"},"PeriodicalIF":9.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144997787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpreting the mandibular jaw movement signal in pediatric obstructive sleep apnea diagnosis: A technical and practical review 解释下颌骨运动信号在儿童阻塞性睡眠呼吸暂停诊断:技术和实践综述
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-08-29 DOI: 10.1016/j.smrv.2025.102159
Jean-Benoit Martinot , Nhat-Nam Le-Dong , Julie Cassibba , Didier Clause , Jean-Louis Pépin , David Gozal
Pediatric obstructive sleep apnea (OSA) is a common yet often underdiagnosed condition, partly due to limited access to polysomnography. Mandibular jaw movement (MJM) analysis offers a promising alternative to conventional home sleep apnea testing in children, capturing the dynamic interactions between respiratory drive and upper airway musculature, enabling accurate identification of, and critical insights into, sleep-disordered breathing events.
This technical and practical review provides a structured framework for understanding and interpreting MJM signals during sleep in pediatric patients. It begins with the physiological basis and technical aspects of using a single-point contact device with integrated inertial sensors. It offers step-by-step instructions for interpreting MJM signals, from distinguishing sleep stages to identifying obstructive and central apneas, hypopneas, and respiratory effort-related arousals. The review is accompanied by an atlas of 30 annotated examples that illustrate key MJM signal patterns across scoring tasks.
Key findings from several clinical studies on the utility of MJM analysis in pediatric OSA are also summarized.
As the demand for accessible and accurate home-based diagnostic tools grows, MJM analysis stands out as an effective option for both the diagnosis and monitoring of pediatric OSA, with the potential to transform routine clinical practice and improve patient access to care.
儿童阻塞性睡眠呼吸暂停(OSA)是一种常见但常被诊断不足的疾病,部分原因是由于多导睡眠图的限制。下颌运动(MJM)分析为传统的儿童家庭睡眠呼吸暂停测试提供了一个有希望的替代方案,捕捉呼吸驱动和上呼吸道肌肉组织之间的动态相互作用,能够准确识别和关键洞察睡眠呼吸障碍事件。这项技术和实践综述为理解和解释儿科患者睡眠中的MJM信号提供了一个结构化的框架。它从使用集成惯性传感器的单点接触装置的生理基础和技术方面开始。它为解释MJM信号提供了一步一步的指导,从区分睡眠阶段到识别阻塞性和中枢性呼吸暂停、低呼吸和呼吸努力相关的唤醒。该审查是伴随着30个注释的例子,说明关键的MJM信号模式跨评分任务的地图集。总结了几项关于MJM分析在儿童OSA中的应用的临床研究的主要发现。随着对可获得和准确的家庭诊断工具的需求不断增长,MJM分析作为儿科OSA诊断和监测的有效选择脱颖而出,具有改变常规临床实践和改善患者获得护理的潜力。
{"title":"Interpreting the mandibular jaw movement signal in pediatric obstructive sleep apnea diagnosis: A technical and practical review","authors":"Jean-Benoit Martinot ,&nbsp;Nhat-Nam Le-Dong ,&nbsp;Julie Cassibba ,&nbsp;Didier Clause ,&nbsp;Jean-Louis Pépin ,&nbsp;David Gozal","doi":"10.1016/j.smrv.2025.102159","DOIUrl":"10.1016/j.smrv.2025.102159","url":null,"abstract":"<div><div>Pediatric obstructive sleep apnea (OSA) is a common yet often underdiagnosed condition, partly due to limited access to polysomnography. Mandibular jaw movement (MJM) analysis offers a promising alternative to conventional home sleep apnea testing in children, capturing the dynamic interactions between respiratory drive and upper airway musculature, enabling accurate identification of, and critical insights into, sleep-disordered breathing events.</div><div>This technical and practical review provides a structured framework for understanding and interpreting MJM signals during sleep in pediatric patients. It begins with the physiological basis and technical aspects of using a single-point contact device with integrated inertial sensors. It offers step-by-step instructions for interpreting MJM signals, from distinguishing sleep stages to identifying obstructive and central apneas, hypopneas, and respiratory effort-related arousals. The review is accompanied by an atlas of 30 annotated examples that illustrate key MJM signal patterns across scoring tasks.</div><div>Key findings from several clinical studies on the utility of MJM analysis in pediatric OSA are also summarized.</div><div>As the demand for accessible and accurate home-based diagnostic tools grows, MJM analysis stands out as an effective option for both the diagnosis and monitoring of pediatric OSA, with the potential to transform routine clinical practice and improve patient access to care.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102159"},"PeriodicalIF":9.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144997788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Botulinum toxin therapy for neurological disorders: Serendipitous benefits on sleep quality and underlying mechanisms 肉毒杆菌毒素治疗神经系统疾病:对睡眠质量的偶然益处及其潜在机制
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-01 DOI: 10.1016/j.smrv.2025.102181
Guiying Kuang , Qinwei Yu , Danfang Yu , Long Liu , Xinyu Hu , Hanshu Liu , Xinyi Wang , Jingwen Li , Jinsha Huang , Tao Wang , Allison J. Cash , Zhicheng Lin , Nian Xiong
Botulinum toxin (BoNT) remains the gold standard treatment for focal and segmental dystonia and is widely used in managing hyperkinetic disorders, chronic pain, and glandular hypersecretion. Extensive clinical trials demonstrate that BoNT effectively ameliorates both the core symptoms of these neurological conditions and their frequently associated comorbidities, including depression, anxiety, and diminished quality of life. Notably, many BoNT-treated neurological disorders co-occur with sleep disturbances, yet sleep outcomes remain underexplored. This review synthesizes current evidence on sleep outcomes following BoNT treatment of both established neurological indications (e.g., neuropathic pain, chronic migraine, dystonia, spasticity, sialorrhea, hemifacial spasm, bladder dysfunction) and primary sleep disorders (e.g., restless legs syndrome, sleep bruxism, insomnia). As a result, BoNT treatment improves sleep outcomes across both categories, potentially through mechanisms involving modulation of vasomotor tone, hormonal secretion, neural activity, mood, and pain perception. However, larger, rigorously designed randomized controlled trials are essential to definitively confirm these therapeutic effects and elucidate the underlying neurobiological mechanisms.
肉毒杆菌毒素(BoNT)仍然是局灶性和节段性肌张力障碍的金标准治疗方法,广泛用于治疗多动障碍、慢性疼痛和腺体分泌亢进。大量的临床试验表明BoNT有效地改善了这些神经系统疾病的核心症状及其经常相关的合并症,包括抑郁、焦虑和生活质量下降。值得注意的是,许多bont治疗的神经系统疾病与睡眠障碍同时发生,但睡眠结果仍未得到充分研究。本综述综合了BoNT治疗已建立的神经系统适应症(如神经性疼痛、慢性偏头痛、肌张力障碍、痉挛、唾液分泌、面肌痉挛、膀胱功能障碍)和原发性睡眠障碍(如不宁腿综合征、睡眠磨牙症、失眠)后睡眠结果的现有证据。因此,BoNT治疗可以通过调节血管舒缩张力、激素分泌、神经活动、情绪和疼痛感知等机制改善两类患者的睡眠结果。然而,更大规模、严格设计的随机对照试验对于明确证实这些治疗效果和阐明潜在的神经生物学机制至关重要。
{"title":"Botulinum toxin therapy for neurological disorders: Serendipitous benefits on sleep quality and underlying mechanisms","authors":"Guiying Kuang ,&nbsp;Qinwei Yu ,&nbsp;Danfang Yu ,&nbsp;Long Liu ,&nbsp;Xinyu Hu ,&nbsp;Hanshu Liu ,&nbsp;Xinyi Wang ,&nbsp;Jingwen Li ,&nbsp;Jinsha Huang ,&nbsp;Tao Wang ,&nbsp;Allison J. Cash ,&nbsp;Zhicheng Lin ,&nbsp;Nian Xiong","doi":"10.1016/j.smrv.2025.102181","DOIUrl":"10.1016/j.smrv.2025.102181","url":null,"abstract":"<div><div>Botulinum toxin (BoNT) remains the gold standard treatment for focal and segmental dystonia and is widely used in managing hyperkinetic disorders, chronic pain, and glandular hypersecretion. Extensive clinical trials demonstrate that BoNT effectively ameliorates both the core symptoms of these neurological conditions and their frequently associated comorbidities, including depression, anxiety, and diminished quality of life. Notably, many BoNT-treated neurological disorders co-occur with sleep disturbances, yet sleep outcomes remain underexplored. This review synthesizes current evidence on sleep outcomes following BoNT treatment of both established neurological indications (e.g., neuropathic pain, chronic migraine, dystonia, spasticity, sialorrhea, hemifacial spasm, bladder dysfunction) and primary sleep disorders (e.g., restless legs syndrome, sleep bruxism, insomnia). As a result, BoNT treatment improves sleep outcomes across both categories, potentially through mechanisms involving modulation of vasomotor tone, hormonal secretion, neural activity, mood, and pain perception. However, larger, rigorously designed randomized controlled trials are essential to definitively confirm these therapeutic effects and elucidate the underlying neurobiological mechanisms.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102181"},"PeriodicalIF":9.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145267605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corpus callosum agenesis: does sleep matter? 胼胝体发育:睡眠重要吗?
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-11-11 DOI: 10.1016/j.smrv.2025.102202
Ludovica Pasca , Helene Vitali , Sara Uccella , Carlo Alberto Quaranta , Lia Macina , Lynn K. Paul , Valentina De Giorgis , Valentina Franco , Renato Borgatti , Romina Romaniello
Agenesis of the corpus callosum is a brain malformation that can lead to intellectual, behavioural, social and emotional impairments, with outcomes varying based on severity. Sleep disturbances are common in children with this disorder, and some studies have evidenced the role of corpus callosum in interhemispheric synchronisation that may influence sleep patterns. This narrative review attempted to intercept available information on sleep in patients with isolated Agenesis of the corpus callosum, partial and complete, across different ages. Since literature about this issue is underdeveloped, knowledge on callostomized individuals has been included. Corpus callosum disruption is linked to sleep disturbances, especially in early life, though the corpus callosum specific contribution remains unclear. Studies on callostomized individuals suggest that the corpus callosum plays a role in slow-wave transmission across hemispheres, which may affect sleep architecture and plasticity. The impaired transfer of brain activity between the hemispheres also seems to influence their dream experiences. The discussion pointed out that sleep problems in patients with Agenesis of the corpus callosum should be systematically assessed, as they may impact neurodevelopment and overall well-being, highlighting the need for further research and sleep interventions.
胼胝体发育不全是一种大脑畸形,可导致智力、行为、社交和情感障碍,其结果因严重程度而异。睡眠障碍在患有这种疾病的儿童中很常见,一些研究已经证明胼胝体在半球间同步中的作用可能会影响睡眠模式。这篇叙述性的综述试图在不同年龄的孤立性胼胝体发育不全和完全性胼胝体发育不全患者中截取可用的睡眠信息。由于关于这个问题的文献不发达,关于胼胝质的个体的知识也被包括在内。胼胝体的破坏与睡眠障碍有关,尤其是在生命早期,尽管胼胝体的具体贡献尚不清楚。对胼胝体个体的研究表明,胼胝体在跨半球的慢波传输中起作用,这可能影响睡眠结构和可塑性。大脑活动在两个半球之间的转移受损似乎也会影响他们的梦境体验。讨论指出,应系统评估胼胝体发育不全患者的睡眠问题,因为它们可能影响神经发育和整体健康,强调需要进一步研究和睡眠干预。
{"title":"Corpus callosum agenesis: does sleep matter?","authors":"Ludovica Pasca ,&nbsp;Helene Vitali ,&nbsp;Sara Uccella ,&nbsp;Carlo Alberto Quaranta ,&nbsp;Lia Macina ,&nbsp;Lynn K. Paul ,&nbsp;Valentina De Giorgis ,&nbsp;Valentina Franco ,&nbsp;Renato Borgatti ,&nbsp;Romina Romaniello","doi":"10.1016/j.smrv.2025.102202","DOIUrl":"10.1016/j.smrv.2025.102202","url":null,"abstract":"<div><div>Agenesis of the corpus callosum is a brain malformation that can lead to intellectual, behavioural, social and emotional impairments, with outcomes varying based on severity. Sleep disturbances are common in children with this disorder, and some studies have evidenced the role of corpus callosum in interhemispheric synchronisation that may influence sleep patterns. This narrative review attempted to intercept available information on sleep in patients with isolated Agenesis of the corpus callosum, partial and complete, across different ages. Since literature about this issue is underdeveloped, knowledge on callostomized individuals has been included. Corpus callosum disruption is linked to sleep disturbances, especially in early life, though the corpus callosum specific contribution remains unclear. Studies on callostomized individuals suggest that the corpus callosum plays a role in slow-wave transmission across hemispheres, which may affect sleep architecture and plasticity. The impaired transfer of brain activity between the hemispheres also seems to influence their dream experiences. The discussion pointed out that sleep problems in patients with Agenesis of the corpus callosum should be systematically assessed, as they may impact neurodevelopment and overall well-being, highlighting the need for further research and sleep interventions.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102202"},"PeriodicalIF":9.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145528009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the obstructive sleep apnea and restless legs syndrome comorbidity (Co-ROSA): A systematic review 探讨阻塞性睡眠呼吸暂停和不宁腿综合征共病(Co-ROSA):一项系统综述。
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-09-30 DOI: 10.1016/j.smrv.2025.102178
Jonathan Tam , Diego Garcia Borreguero , Lourdes M. DelRosso

Objective

To systematically evaluate the prevalence, clinical profiles, and treatment outcomes in patients with comorbid RLS and OSA and to assess the impact of OSA therapy on RLS symptoms.

Methods

We conducted a systematic review of observational studies indexed in MedLine, PubMed, and EMBASE through August 2025. The review followed PRISMA guidelines and was registered in PROSPERO. The Inclusion criteria were studies reporting original data on adult patients with comorbid RLS and OSA, including clinical features and treatment outcomes. Study quality was assessed using the NIH Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies.

Results

Ten studies were included, comprising over 3000 participants. The prevalence of RLS among patients with OSA ranged from 10 % to 30 %. Comorbidity was associated with increased rates of insomnia, fatigue, depression, and reduced response to OSA therapy. In multiple studies, CPAP treatment led to improvement in RLS symptoms, including reduced medication use in over 70 % of patients in some cohorts. However, therapeutic response was variable, with some patients exhibiting persistent or CPAP-emergent periodic limb movements. The quality of the studies included was mainly fair, with two rated as good.

Conclusions

Comorbid RLS and OSA represent a clinically distinct phenotype characterized by a greater symptom burden and more complex treatment trajectories. CPAP may offer therapeutic benefit for RLS in many patients.
目的:系统评估RLS和OSA合并症患者的患病率、临床概况和治疗结果,并评估OSA治疗对RLS症状的影响。方法:我们对截至2025年8月在MedLine、PubMed和EMBASE中检索的观察性研究进行了系统回顾。该审查遵循PRISMA的指导方针,并在PROSPERO进行了登记。纳入标准是报告患有RLS和OSA合并症的成人患者的原始数据的研究,包括临床特征和治疗结果。使用美国国立卫生研究院观察性队列和横断面研究质量评估工具评估研究质量。结果:纳入10项研究,3000多名参与者。在OSA患者中,RLS的患病率从10%到30%不等。合并症与失眠、疲劳、抑郁的发生率增加以及对OSA治疗的反应降低有关。在多项研究中,CPAP治疗可改善RLS症状,包括在一些队列中超过70%的患者减少药物使用。然而,治疗反应是可变的,一些患者表现出持续的或cpap出现的周期性肢体运动。纳入研究的质量基本上是一般的,其中两项被评为良好。结论:合并症RLS和OSA表现出一种临床不同的表型,其特征是更大的症状负担和更复杂的治疗轨迹。CPAP可能为许多患者的RLS提供治疗益处。
{"title":"Exploring the obstructive sleep apnea and restless legs syndrome comorbidity (Co-ROSA): A systematic review","authors":"Jonathan Tam ,&nbsp;Diego Garcia Borreguero ,&nbsp;Lourdes M. DelRosso","doi":"10.1016/j.smrv.2025.102178","DOIUrl":"10.1016/j.smrv.2025.102178","url":null,"abstract":"<div><h3>Objective</h3><div>To systematically evaluate the prevalence, clinical profiles, and treatment outcomes in patients with comorbid RLS and OSA and to assess the impact of OSA therapy on RLS symptoms.</div></div><div><h3>Methods</h3><div>We conducted a systematic review of observational studies indexed in MedLine, PubMed, and EMBASE through August 2025. The review followed PRISMA guidelines and was registered in PROSPERO. The Inclusion criteria were studies reporting original data on adult patients with comorbid RLS and OSA, including clinical features and treatment outcomes. Study quality was assessed using the NIH Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies.</div></div><div><h3>Results</h3><div>Ten studies were included, comprising over 3000 participants. The prevalence of RLS among patients with OSA ranged from 10 % to 30 %. Comorbidity was associated with increased rates of insomnia, fatigue, depression, and reduced response to OSA therapy. In multiple studies, CPAP treatment led to improvement in RLS symptoms, including reduced medication use in over 70 % of patients in some cohorts. However, therapeutic response was variable, with some patients exhibiting persistent or CPAP-emergent periodic limb movements. The quality of the studies included was mainly fair, with two rated as good.</div></div><div><h3>Conclusions</h3><div>Comorbid RLS and OSA represent a clinically distinct phenotype characterized by a greater symptom burden and more complex treatment trajectories. CPAP may offer therapeutic benefit for RLS in many patients.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102178"},"PeriodicalIF":9.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145253597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recreational cannabis use and sleep in the general population: a systematic review and meta-analysis 普通人群的娱乐性大麻使用和睡眠:一项系统回顾和荟萃分析。
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-30 DOI: 10.1016/j.smrv.2025.102189
Fangxiang Mao , Sanne J.W. Hoepel , Mina Shahisavandi , Annemarie I. Luik , Hanan EI Marroun
Cannabis use is often used to improve sleep, yet it remains unclear whether its recreational use, either current or lifetime, is associated with better sleep in the general population. We conducted a systematic review and meta-analysis of 120 studies identified from six databases, excluding studies on medicinal cannabis or clinical samples. Current use was defined as cannabis use within one month, and lifetime use as use in the past year or lifetime. Among 102 observational studies identified, current recreational cannabis use was associated with poorer sleep quality, both short and long sleep duration, more insomnia symptoms, and a later chronotype, compared to non-use. Lifetime use showed similar associations with insomnia and chronotype. Neither current nor lifetime use was linked to daytime sleepiness. These associations were more pronounced among men and younger users. In contrast, no associations between cannabis and sleep quality and duration were observed across 19 experimental studies. Overall, recreational cannabis use was linked to poorer sleep across multiple components in observational studies although these findings may be affected by bias. Given the ethical and practical limitations of long-term trials, integrating well-designed observational and experimental research is essential to fully understand how cannabis use links to sleep.
大麻的使用通常被用来改善睡眠,但目前尚不清楚其娱乐性使用,无论是目前还是终生,是否与普通人群的更好睡眠有关。我们对来自6个数据库的120项研究进行了系统回顾和荟萃分析,排除了药用大麻或临床样本的研究。当前使用定义为一个月内使用大麻,终生使用定义为过去一年或一生中使用大麻。在已确定的102项观察性研究中,与不使用大麻相比,目前娱乐性大麻的使用与较差的睡眠质量、较短的睡眠时间和较长的睡眠时间、更多的失眠症状和较晚的睡眠类型有关。终生使用与失眠和生物钟类型有相似的联系。目前或终生使用都与白天嗜睡无关。这些关联在男性和年轻用户中更为明显。相比之下,在19项实验研究中,大麻与睡眠质量和持续时间之间没有联系。总体而言,在观察性研究中,娱乐性大麻的使用与较差的睡眠有关,尽管这些发现可能受到偏见的影响。考虑到长期试验的伦理和实际限制,整合精心设计的观察和实验研究对于充分了解大麻使用与睡眠的关系至关重要。
{"title":"Recreational cannabis use and sleep in the general population: a systematic review and meta-analysis","authors":"Fangxiang Mao ,&nbsp;Sanne J.W. Hoepel ,&nbsp;Mina Shahisavandi ,&nbsp;Annemarie I. Luik ,&nbsp;Hanan EI Marroun","doi":"10.1016/j.smrv.2025.102189","DOIUrl":"10.1016/j.smrv.2025.102189","url":null,"abstract":"<div><div>Cannabis use is often used to improve sleep, yet it remains unclear whether its recreational use, either current or lifetime, is associated with better sleep in the general population. We conducted a systematic review and meta-analysis of 120 studies identified from six databases, excluding studies on medicinal cannabis or clinical samples. Current use was defined as cannabis use within one month, and lifetime use as use in the past year or lifetime. Among 102 observational studies identified, current recreational cannabis use was associated with poorer sleep quality, both short and long sleep duration, more insomnia symptoms, and a later chronotype, compared to non-use. Lifetime use showed similar associations with insomnia and chronotype. Neither current nor lifetime use was linked to daytime sleepiness. These associations were more pronounced among men and younger users. In contrast, no associations between cannabis and sleep quality and duration were observed across 19 experimental studies. Overall, recreational cannabis use was linked to poorer sleep across multiple components in observational studies although these findings may be affected by bias. Given the ethical and practical limitations of long-term trials, integrating well-designed observational and experimental research is essential to fully understand how cannabis use links to sleep.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102189"},"PeriodicalIF":9.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145446376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Behavioural sleep interventions for the management of non-respiratory sleep disorders in children with neurodisability 行为睡眠干预对神经残疾儿童非呼吸性睡眠障碍的管理
IF 9.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-10-29 DOI: 10.1016/j.smrv.2025.102185
Kasey Fullwood , Karen Thorpe , Laetitia Coles , Moya Vandeleur , Karen Waters , Jasneek Chawla
Non-respiratory sleep disorders, including behavioural sleep disorders (e.g., difficulty with sleep onset and sleep maintenance) affect up to 80 % of children with neurodisability (ND). Non-respiratory sleep disorders in typically developing children can be treated using a variety of behavioural strategies and interventions, however generalisability of these interventions to children with ND remains uncertain. A systematic search of databases revealed 55 papers that were included in this review. Most (69 %) studies focused on children with ASD and/or ADHD with a limited number found in other disability groups. Intervention delivery mode varied with 13 % using an online format and 87 % in person, with group (44 %) and individual (52 %) approaches exhibiting similar efficacy. Results outlined key findings; 1) The breadth of ND conditions included is limited 2) small sample size across the majority of studies 3) interventions may need to be adapted to improve effectiveness 4) while mode of delivery varied, effects were similar and 5) highest intensity programs were not the most effective. Our review shows that while sleep strategies and interventions can be effective in treating non-respiratory sleep disorders in this cohort, more evidence is required to determine how best to tailor these to address challenges that are unique to children with ND.
非呼吸性睡眠障碍,包括行为性睡眠障碍(例如,入睡困难和睡眠维持困难)影响多达80%的神经残疾儿童。典型发育儿童的非呼吸性睡眠障碍可以使用多种行为策略和干预措施进行治疗,但这些干预措施对ND儿童的普遍性仍不确定。通过对数据库的系统检索,我们发现这篇综述中包含了55篇论文。大多数(69%)的研究集中在患有ASD和/或ADHD的儿童身上,在其他残疾群体中发现的数量有限。干预交付模式各不相同,13%采用在线形式,87%采用面对面的方式,群体(44%)和个人(52%)的方式表现出相似的效果。结果概述了主要发现;1)纳入的ND条件的广度有限2)大多数研究的样本量小3)干预措施可能需要调整以提高有效性4)虽然交付模式不同,但效果相似5)最高强度的方案不是最有效的。我们的回顾表明,虽然睡眠策略和干预措施可以有效地治疗该队列中的非呼吸性睡眠障碍,但需要更多的证据来确定如何最好地调整这些策略和干预措施,以应对ND儿童独有的挑战。
{"title":"Behavioural sleep interventions for the management of non-respiratory sleep disorders in children with neurodisability","authors":"Kasey Fullwood ,&nbsp;Karen Thorpe ,&nbsp;Laetitia Coles ,&nbsp;Moya Vandeleur ,&nbsp;Karen Waters ,&nbsp;Jasneek Chawla","doi":"10.1016/j.smrv.2025.102185","DOIUrl":"10.1016/j.smrv.2025.102185","url":null,"abstract":"<div><div>Non-respiratory sleep disorders, including behavioural sleep disorders (e.g., difficulty with sleep onset and sleep maintenance) affect up to 80 % of children with neurodisability (ND). Non-respiratory sleep disorders in typically developing children can be treated using a variety of behavioural strategies and interventions, however generalisability of these interventions to children with ND remains uncertain. A systematic search of databases revealed 55 papers that were included in this review. Most (69 %) studies focused on children with ASD and/or ADHD with a limited number found in other disability groups. Intervention delivery mode varied with 13 % using an online format and 87 % in person, with group (44 %) and individual (52 %) approaches exhibiting similar efficacy. Results outlined key findings; 1) The breadth of ND conditions included is limited 2) small sample size across the majority of studies 3) interventions may need to be adapted to improve effectiveness 4) while mode of delivery varied, effects were similar and 5) highest intensity programs were not the most effective. Our review shows that while sleep strategies and interventions can be effective in treating non-respiratory sleep disorders in this cohort, more evidence is required to determine how best to tailor these to address challenges that are unique to children with ND.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"84 ","pages":"Article 102185"},"PeriodicalIF":9.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145466356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Sleep Medicine Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1